X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare WYETH LTD with Dishman Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD vs DISHMAN PHARMA - Comparison Results

WYETH LTD    Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DISHMAN PHARMA 
   Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH LTD DISHMAN PHARMA WYETH LTD/
DISHMAN PHARMA
 
P/E (TTM) x 27.7 25.1 110.5% View Chart
P/BV x 5.3 3.3 159.8% View Chart
Dividend Yield % 1.3 0.7 191.7%  

Financials

 WYETH LTD   DISHMAN PHARMA
EQUITY SHARE DATA
    WYETH LTD
Mar-13
DISHMAN PHARMA
Mar-16
WYETH LTD/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs1,044374 279.0%   
Low Rs818129 634.6%   
Sales per share (Unadj.) Rs298.6197.8 150.9%  
Earnings per share (Unadj.) Rs57.221.2 269.9%  
Cash flow per share (Unadj.) Rs58.434.7 168.2%  
Dividends per share (Unadj.) Rs17.002.00 850.0%  
Dividend yield (eoy) %1.80.8 229.7%  
Book value per share (Unadj.) Rs249.5179.9 138.7%  
Shares outstanding (eoy) m22.7280.69 28.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.11.3 245.2%   
Avg P/E ratio x16.311.9 137.1%  
P/CF ratio (eoy) x15.97.2 220.0%  
Price / Book Value ratio x3.71.4 266.8%  
Dividend payout %29.79.4 314.9%   
Avg Mkt Cap Rs m21,15720,306 104.2%   
No. of employees `0000.50.8 59.3%   
Total wages/salary Rs m4005,355 7.5%   
Avg. sales/employee Rs Th13,787.419,252.7 71.6%   
Avg. wages/employee Rs Th813.06,459.5 12.6%   
Avg. net profit/employee Rs Th2,643.32,064.1 128.1%   
INCOME DATA
Net Sales Rs m6,78315,961 42.5%  
Other income Rs m353265 132.9%   
Total revenues Rs m7,13616,226 44.0%   
Gross profit Rs m1,6174,103 39.4%  
Depreciation Rs m271,091 2.4%   
Interest Rs m6944 0.6%   
Profit before tax Rs m1,9382,334 83.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m01 0.0%   
Extraordinary Inc (Exp) Rs m-50-   
Tax Rs m632624 101.4%   
Profit after tax Rs m1,3011,711 76.0%  
Gross profit margin %23.825.7 92.7%  
Effective tax rate %32.626.7 122.1%   
Net profit margin %19.210.7 178.8%  
BALANCE SHEET DATA
Current assets Rs m6,98411,018 63.4%   
Current liabilities Rs m2,0569,517 21.6%   
Net working cap to sales %72.69.4 772.5%  
Current ratio x3.41.2 293.4%  
Inventory Days Days99110 89.8%  
Debtors Days Days2435 68.7%  
Net fixed assets Rs m24416,304 1.5%   
Share capital Rs m227161 140.8%   
"Free" reserves Rs m5,44112,907 42.2%   
Net worth Rs m5,66814,516 39.0%   
Long term debt Rs m254,189 0.6%   
Total assets Rs m7,90129,805 26.5%  
Interest coverage x353.33.5 10,179.4%   
Debt to equity ratio x00.3 1.5%  
Sales to assets ratio x0.90.5 160.3%   
Return on assets %16.58.9 185.5%  
Return on equity %22.911.8 194.6%  
Return on capital %34.017.5 194.2%  
Exports to sales %0.224.8 0.9%   
Imports to sales %36.33.7 972.8%   
Exports (fob) Rs m153,956 0.4%   
Imports (cif) Rs m2,465596 413.4%   
Fx inflow Rs m154,952 0.3%   
Fx outflow Rs m2,677697 384.2%   
Net fx Rs m-2,6624,255 -62.6%   
CASH FLOW
From Operations Rs m9232,786 33.1%  
From Investments Rs m317-1,529 -20.7%  
From Financial Activity Rs m-481-941 51.1%  
Net Cashflow Rs m759316 239.9%  

Share Holding

Indian Promoters % 0.0 61.4 -  
Foreign collaborators % 51.1 0.0 -  
Indian inst/Mut Fund % 11.3 3.7 305.4%  
FIIs % 7.2 12.7 56.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 22.1 137.6%  
Shareholders   21,978 46,261 47.5%  
Pledged promoter(s) holding % 0.0 35.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH LTD With:   ALEMBIC PHARMA  FRESENIUS KABI ONCO.  FDC LTD.  ASTRAZENECA PHARMA  BIOCON LTD  

Compare WYETH LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

OPEC Meeting; Upcoming IPOs; IDBI Bank, Emami among Top Stocks in Action Today(Pre-Open)

Indian share markets edged up on Friday with Nifty 50 closing above 10,800-levels, even as broader global markets remained weak.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

This Behaviour is Injurious to Wealth Building(Sector Info)

Jun 13, 2018

Blindly following the herd can be the biggest wealth destroyer.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WYETH LTD SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE WYETH LTD WITH

MARKET STATS